Evidence map›Paper›PMID 33351125›Full record

ArticleBlood advances2020

Chronic lymphocytic leukemia increases the pool of peripheral blood hematopoietic stem cells and skews differentiation.

Antonella Santoro, Camelia Andrei, Clare Bryant, Emily Calderbank, Alison Wray, Joanna E Baxter, Anna Godfrey, Elisa Laurenti, Ingo Ringshausen

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood advances, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Antonella SantoroDepartment of Haematology and Wellcome and MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom.
Camelia AndreiHaematopathology & Oncology Diagnostics Service, Department of Haematology Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom; and.
Clare BryantHaematopathology & Oncology Diagnostics Service, Department of Haematology Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom; and.
Emily CalderbankDepartment of Haematology and Wellcome and MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom.
Alison WrayCambridge Blood and Stem Cell Biobank, University of Cambridge, United Kingdom.
Joanna E BaxterCambridge Blood and Stem Cell Biobank, University of Cambridge, United Kingdom.
Anna GodfreyHaematopathology & Oncology Diagnostics Service, Department of Haematology Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom; and.
Elisa LaurentiDepartment of Haematology and Wellcome and MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom.
Ingo RingshausenDepartment of Haematology and Wellcome and MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom.

Funding

Biotechnology and Biological Sciences Research CouncilCancer Research UK 17480Medical Research Council MC_PC_12009Medical Research Council MC_PC_17230Medical Research Council MR/M008975/1Wellcome Trust
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hematopoietic Stem Cell TransplantationLeukemia, Lymphocytic, Chronic, B-CellCell DifferentiationHematopoietic Stem CellsHumans

Identifiers

PMID33351125
PMCPMC7756989

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.